MCID: CYT005
MIFTS: 47

Cytomegalovirus Retinitis malady

Categories: Rare diseases, Eye diseases

Aliases & Classifications for Cytomegalovirus Retinitis

Aliases & Descriptions for Cytomegalovirus Retinitis:

Name: Cytomegalovirus Retinitis 12 50 42 14 69
Cmv Retinitis 12 52

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Eye diseases


External Ids:

Disease Ontology 12 DOID:0080160
MeSH 42 D017726

Summaries for Cytomegalovirus Retinitis

Disease Ontology : 12 A retinitis that has material basis in Cytomegalovirus.

MalaCards based summary : Cytomegalovirus Retinitis, also known as cmv retinitis, is related to cataract and rheumatoid arthritis. An important gene associated with Cytomegalovirus Retinitis is IL10RA (Interleukin 10 Receptor Subunit Alpha), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Cidofovir and Ganciclovir have been mentioned in the context of this disorder. Affiliated tissues include eye, retina and t cells, and related phenotypes are cellular and hematopoietic system

Wikipedia : 71 Cytomegalovirus retinitis, also known as CMV retinitis, is an inflammation of the retina of the eye that... more...

Related Diseases for Cytomegalovirus Retinitis

Diseases related to Cytomegalovirus Retinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 140)
id Related Disease Score Top Affiliating Genes
1 cataract 29.8 CSF2 TNF
2 rheumatoid arthritis 28.5 CCR2 CSF2 HLA-DQB1 IFNG TNF
3 retinitis 10.9
4 acquired immunodeficiency syndrome 10.3
5 glaucoma iridogoniodysgenesia 10.2 HLA-B IL10RA
6 uveitis 10.2
7 immune deficiency, familial variable 10.2 HLA-B HLA-DQB1
8 learning disability 10.2 HLA-B HLA-DQB1
9 retinal detachment 10.2
10 bilateral parasagittal parieto-occipital polymicrogyria 10.2 HLA-DQB1 TNF
11 cervical adenoid basal carcinoma 10.2 HLA-B HLA-DQB1
12 autosomal dominant intermediate charcot-marie-tooth 10.2 HLA-DQB1 TNF
13 mirizzi syndrome 10.2 HLA-B TNF
14 swine influenza 10.1 HLA-B TNF
15 aortic coarctation 10.1 HLA-B TNF
16 nystagmus, congenital motor, autosomal recessive 10.1 HLA-B TNF
17 aseptic meningitis 10.1 HLA-B TNF
18 pneumoconiosis 10.1 HLA-DQB1 TNF
19 deep dermatophytosis 10.0 HLA-DQB1 IFNG
20 subclavian artery aneurysm 10.0 CSF2 IFNG
21 carcinoid tumor childhood 10.0 CSF2 IFNG
22 hutchinson incisors 10.0 CSF2 IFNG
23 cryptococcosis 10.0 HLA-B HLA-DQB1 TNF
24 stocco dos santos syndrome 10.0 IFNG TNF
25 autosomal dominant deafness-onychodystrophy syndrome 10.0 IFNG TNF
26 grix blankenship peterson syndrome 10.0 CSF2 TNF
27 parasitic helminthiasis infectious disease 10.0 HLA-B HLA-DQB1 TNF
28 severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive 10.0 IFNG TNF
29 microscopic breast papilloma 10.0 HLA-B HLA-DQB1 TNF
30 myofibroma 10.0 HLA-DQB1 IFNG
31 otulipenia 10.0 CSF2 IFNG
32 t-cell prolymphocytic leukemia 10.0 CCR5 HLA-DQB1 TNF
33 urethral intrinsic sphincter deficiency 10.0 IFNG TNF
34 membranoproliferative glomerulonephritis 10.0 CCR5 CSF2 TNF
35 plantar wart 10.0 IFNG TNF
36 amyotrophic lateral sclerosis type 14 10.0 IFNG TNF
37 parotid gland cancer 10.0 HLA-B HLA-DQB1 TNF
38 parametritis 10.0 IFNG TNF
39 acanthoma 10.0 HLA-B IFNG
40 hypotrichosis 4 10.0 IFNG TNF
41 spastic paraplegia 1 10.0 IFNG TNF
42 parkinson disease 11 10.0 IFNG TNF
43 lymphoma 10.0
44 neurotic disorder 9.9 IFNG TNF
45 leukemia 9.9
46 good syndrome 9.9
47 venezuelan hemorrhagic fever 9.9 IFNG TNF
48 glucose intolerance 9.9 IFNG TNF
49 bickerstaff brainstem encephalitis 9.9 HLA-B HLA-DQB1 IFNG
50 senile reticular retinal degeneration 9.9 IFNG TNF

Graphical network of the top 20 diseases related to Cytomegalovirus Retinitis:



Diseases related to Cytomegalovirus Retinitis

Symptoms & Phenotypes for Cytomegalovirus Retinitis

MGI Mouse Phenotypes related to Cytomegalovirus Retinitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.98 CCR2 CCR5 CSF2 HLA-DQB1 IFNG IL10RA
2 hematopoietic system MP:0005397 9.97 CCR2 CCR5 CD9 CSF2 HLA-DQB1 IFNG
3 cardiovascular system MP:0005385 9.93 TNF CCR2 CCR5 CSF2 HLA-DQB1 IFNG
4 immune system MP:0005387 9.92 CCR2 CCR5 CD9 CSF2 HLA-DQB1 IFNG
5 digestive/alimentary MP:0005381 9.88 CCR2 CCR5 HLA-DQB1 IFNG IL10RA TNF
6 liver/biliary system MP:0005370 9.65 HLA-DQB1 IFNG TNF CCR2 CCR5
7 neoplasm MP:0002006 9.55 CCR2 CCR5 CSF2 IFNG TNF
8 reproductive system MP:0005389 9.43 CCR5 CD9 CSF2 HLA-DQB1 IFNG TNF
9 respiratory system MP:0005388 9.1 HLA-DQB1 IFNG TNF CCR2 CD9 CSF2

Drugs & Therapeutics for Cytomegalovirus Retinitis

Drugs for Cytomegalovirus Retinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 118)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cidofovir Approved Phase 4,Phase 3,Phase 2,Phase 1 113852-37-2 60613
2
Ganciclovir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 82410-32-0 3454
3
Foscarnet Approved Phase 4,Phase 3,Phase 2,Phase 1 63585-09-1, 4428-95-9 3415
4
Probenecid Approved Phase 4,Phase 2,Phase 1 57-66-9 4911
5
Phosphonoacetic Acid Experimental Phase 4,Phase 3,Phase 2,Phase 1 4408-78-0 546
6 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
7 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1
8 Ganciclovir triphosphate Phase 4,Phase 3,Phase 2,Phase 1
9 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
10 Anti-Retroviral Agents Phase 4,Phase 3,Phase 2,Phase 1
11 Reverse Transcriptase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
12 Antirheumatic Agents Phase 4,Phase 2,Phase 1
13 Renal Agents Phase 4,Phase 2,Phase 1
14
Valganciclovir Approved, Investigational Phase 3,Phase 2 175865-60-8 64147
15 Antibodies Phase 2, Phase 3,Phase 1
16 Antibodies, Monoclonal Phase 2, Phase 3,Phase 1
17 Immunoglobulins Phase 2, Phase 3,Phase 1
18 Acyclovir Phase 3
19
Nelfinavir Approved Phase 2 159989-64-7 64143
20 Fomivirsen Phase 2
21 Anti-HIV Agents Phase 2,Phase 1
22 HIV Protease Inhibitors Phase 2
23
protease inhibitors Phase 2
24 Fiacitabine Phase 2
25 Pharmaceutical Solutions Phase 2,Phase 1
26
Aldesleukin Approved Phase 1 85898-30-2, 110942-02-4
27 Analgesics Phase 1
28 Analgesics, Non-Narcotic Phase 1
29 Interleukin-2 Phase 1
30 Peripheral Nervous System Agents Phase 1
31
Zidovudine Approved 30516-87-1 35370
32
Interferon beta-1b Approved 145155-23-3
33
Mycophenolate mofetil Approved, Investigational 128794-94-5 5281078
34
Mycophenolic acid Approved 24280-93-1 446541
35
Alfentanil Approved, Illicit 71195-58-9 51263
36
Aripiprazole Approved, Investigational 129722-12-9 60795
37
Ceftazidime Approved 78439-06-2 5481173
38
Ciprofloxacin Approved, Investigational 85721-33-1 2764
39
Clozapine Approved 5786-21-0 2818
40
Dexamethasone Approved, Investigational, Vet_approved 50-02-2 5743
41
Diazepam Approved, Illicit, Vet_approved 439-14-5 3016
42
Epinephrine Approved, Vet_approved 51-43-4 5816
43
Fosphenytoin Approved 93390-81-9 56339
44
Haloperidol Approved 52-86-8 3559
45
Heparin Approved, Investigational 9005-49-6 772 46507594
46
Hydromorphone Approved, Illicit 466-99-9 5284570
47
Meropenem Approved, Investigational 119478-56-7 64778 441130
48
Methylprednisolone Approved, Vet_approved 83-43-2 6741
49
Midazolam Approved, Illicit 59467-70-8 4192
50
Molindone Approved 7416-34-4 23897

Interventional clinical trials:

(show top 50) (show all 72)
id Name Status NCT ID Phase
1 Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis Completed NCT00000894 Phase 4
2 A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) Completed NCT00002125 Phase 4
3 Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration Completed NCT01866397 Phase 4
4 Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection Unknown status NCT00017784 Phase 3
5 A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS Completed NCT00000688 Phase 3
6 Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) Completed NCT00000134 Phase 3
7 Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) Completed NCT00000135 Phase 2, Phase 3
8 A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis Completed NCT00000698 Phase 3
9 Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) Completed NCT00000143 Phase 3
10 Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) Completed NCT00000136 Phase 3
11 Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis Completed NCT00002070 Phase 3
12 Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) Completed NCT00000142 Phase 2, Phase 3
13 Ganciclovir Implant Study for Cytomegalovirus Retinitis Completed NCT00000118 Phase 3
14 A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes Completed NCT00002377 Phase 3
15 Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT) Completed NCT00330018 Phase 3
16 A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) Completed NCT00002156 Phase 2
17 Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis Completed NCT00004794 Phase 2
18 A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure Completed NCT00000691 Phase 2
19 CMV Retinitis Retreatment Trial Completed NCT00000766 Phase 2
20 The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Completed NCT00002437 Phase 2
21 The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes Completed NCT00002356 Phase 2
22 A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis Completed NCT00002169 Phase 2
23 A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT) Completed NCT00000836 Phase 2
24 Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS Completed NCT00001061 Phase 2
25 The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV Completed NCT00001034 Phase 2
26 The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS Completed NCT00000981 Phase 2
27 Congenital CMV and Hearing Loss in Children up to 4 Years of Age: Treating With Valganciclovir Therapy Recruiting NCT01649869 Phase 2
28 Anti-virus Treatment Following Bone Marrow Transplant Recruiting NCT02048332 Phase 1, Phase 2
29 Third Party Anti-Viral Cytotoxic T-Cells Recruiting NCT02532452 Phase 2
30 Cidofovir in Renal Transplant Recipients With BKVN Terminated NCT00138424 Phase 1, Phase 2
31 A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir Withdrawn NCT00000697 Phase 2
32 A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy Completed NCT00000673 Phase 1
33 A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis Completed NCT00002016 Phase 1
34 Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome Completed NCT00000726 Phase 1
35 A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes Completed NCT00001062 Phase 1
36 A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir Completed NCT00000970 Phase 1
37 A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis Completed NCT00002321 Phase 1
38 A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir Completed NCT00000668 Phase 1
39 A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease Completed NCT00000805 Phase 1
40 A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease Withdrawn NCT00000881 Phase 1
41 A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Unknown status NCT00002384
42 A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir Unknown status NCT00002301
43 Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS Completed NCT00000693
44 A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS Completed NCT00002257
45 A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis Completed NCT00002134
46 A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy Completed NCT00002247
47 A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS Completed NCT00002034
48 A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis Completed NCT00002187
49 An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS Completed NCT00002142
50 Efficacy of Elevated CD4 Counts on CMV Retinitis Completed NCT00091884

Search NIH Clinical Center for Cytomegalovirus Retinitis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: cytomegalovirus retinitis

Genetic Tests for Cytomegalovirus Retinitis

Anatomical Context for Cytomegalovirus Retinitis

MalaCards organs/tissues related to Cytomegalovirus Retinitis:

39
Eye, Retina, T Cells, Bone, Bone Marrow, Testes, Endothelial

Publications for Cytomegalovirus Retinitis

Articles related to Cytomegalovirus Retinitis:

(show top 50) (show all 565)
id Title Authors Year
1
Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy. ( 27984023 )
2017
2
Cytokine Profiles in Aqueous Humor and Plasma of HIV-infected Individuals with Ocular Syphilis or Cytomegalovirus Retinitis. ( 28081374 )
2017
3
Management of Cytomegalovirus Retinitis in HIV and Non-HIV Patients. ( 26878441 )
2016
4
Cytomegalovirus Retinitis as the First Manifestation of Good Syndrome. ( 27715373 )
2016
5
Dual Intravitreal Injections With Foscarnet and Ganciclovir for Ganciclovir-Resistant Recurrent Cytomegalovirus Retinitis in a Congenitally Infected Infant. ( 27783090 )
2016
6
Diagnostic Utility of Ocular Symptoms and Vision for Cytomegalovirus Retinitis. ( 27788232 )
2016
7
Leukaemic infiltration and cytomegalovirus retinitis in a patient with acute T-cell lymphoblastic leukaemia in complete remission. ( 27402450 )
2016
8
Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis. ( 27090644 )
2016
9
Sensitivity of the Cytomegalovirus Antigenemia Assay to Diagnose Cytomegalovirus Retinitis. ( 27883376 )
2016
10
Cytomegalovirus retinitis in pediatric stem cell transplants: report of a recent cluster and the development of a screening protocol. ( 27746296 )
2016
11
Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy-a 5-year study from Singapore. ( 27822743 )
2016
12
Cytomegalovirus retinitis in an immunocompetent patient: A case report. ( 27331155 )
2016
13
Long-term Follow-up of Cytomegalovirus Retinitis in Non-HIV Immunocompromised Patients: Clinical Features and Visual Prognosis. ( 27005706 )
2016
14
Cytomegalovirus retinitis. ( 26684874 )
2016
15
In Response to: Jeon and Lee's 'Cytomegalovirus Retinitis in a Human Immunodeficiency Virus-negative Cohort: Long-term Management and Complications'. ( 26943724 )
2016
16
Frosted Branch Angiitis Associated with Cytomegalovirus Retinitis. ( 26902566 )
2016
17
Atypical Retinitis in the Setting of Prior Cytomegalovirus Retinitis. ( 27100908 )
2016
18
Cytomegalovirus Retinitis in a Patient Who Received Ruxolitinib. ( 26789901 )
2016
19
Bilateral Cytomegalovirus Retinitis in a Patient with Systemic Lupus Erythematosus. ( 27462259 )
2016
20
Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature. ( 26809342 )
2016
21
Frosted branch angiitis in acquired immunodeficiency syndrome patients with cytomegalovirus retinitis. ( 27640360 )
2016
22
Cytomegalovirus Retinitis and Uveitis. ( 26471353 )
2015
23
Cytomegalovirus Retinitis in a Human Immunodeficiency Virus-negative Cohort: Long-term Management and Complications. ( 25760914 )
2015
24
Cytomegalovirus retinitis complicating combination therapy with rituximab and fludarabine. ( 25572171 )
2015
25
Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion. ( 25559515 )
2015
26
Management of cytomegalovirus retinitis in HIV infection in the era of highly active antiretroviral therapy. ( 26232735 )
2015
27
Retinal detachment associated with AIDS-related cytomegalovirus retinitis: risk factors in a resource-limited setting. ( 25448999 )
2015
28
Unilateral Ischemic Maculopathy Associated with Cytomegalovirus Retinitis in Patients with AIDS: Optical Coherence Tomography Findings. ( 27051496 )
2015
29
Effective treatment of cytomegalovirus retinitis and neuritis with retrobulbar ganciclovir after treosulfan-based autologous bone marrow transplant. ( 26638547 )
2015
30
Cytomegalovirus Retinitis in HIV-Negative Patients: A Practical Management Approach. ( 25556113 )
2015
31
Immune recovery uveitis in a patient with previously undiagnosed cytomegalovirus retinitis. ( 26531739 )
2015
32
Retrospective study of cytomegalovirus retinitis complicated with acquired immunodeficiency syndrome. ( 26309620 )
2015
33
Incidence Rate and Risk Factors for Contralateral Eye Involvement among Patients with AIDS and Cytomegalovirus Retinitis Treated with Local Therapy. ( 26258284 )
2015
34
Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis. ( 26652481 )
2015
35
Incidence Rate and Risk Factors for Contralateral Eye Involvement among Patients with AIDS and Cytomegalovirus Retinitis Treated with Local Therapy. ( 26327465 )
2015
36
Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort. ( 25892019 )
2015
37
Clinical Outcomes of Retinal Detachment Surgery following Cytomegalovirus Retinitis in Patients on Highly Active Anti-retroviral Therapy for Acquired Immune Deficiency Syndrome. ( 26221740 )
2015
38
Telemedicine screening for cytomegalovirus retinitis at the point of care for human immunodeficiency virus infection. ( 25412344 )
2015
39
Atypical cytomegalovirus retinitis in non-Hodgkin's lymphoma. ( 26240105 )
2015
40
Retinal structural features of cytomegalovirus retinitis with acquired immunodeficiency syndrome: an adaptive optics imaging and optical coherence tomography study. ( 26148637 )
2015
41
Cytomegalovirus Retinitis in Three Pediatric Cases with Acute Lymphoblastic Leukemia: Case Series and Review of the Literature. ( 26567834 )
2015
42
Cytomegalovirus retinitis following intravitreal dexamethasone implant in a patient with central retinal vein occlusion. ( 26172582 )
2015
43
Cytomegalovirus Retinitis in an ALL Child during Maintenance Therapy Treated Successfully with Intravenous Ganciclovir. ( 25161790 )
2014
44
Management of ganciclovir-resistant cytomegalovirus retinitis in HIV infection in the era of antiretroviral therapy. ( 24516078 )
2014
45
A Cytomegalovirus Retinitis Screening Program: Evaluation of Enrollment Criteria for HIV Patients in Singapore. ( 24724869 )
2014
46
Training clinicians treating HIV to diagnose cytomegalovirus retinitis. ( 25552774 )
2014
47
Mortality in Patients With AIDS-Related Cytomegalovirus Retinitis in Myanmar. ( 25121775 )
2014
48
Cytomegalovirus retinitis in acquired immunodeficiency syndrome patients: A problem worth giving attention to. ( 24958981 )
2014
49
Bilateral intraocular calcification in necrotizing cytomegalovirus retinitis. ( 24550055 )
2014
50
Continued decline of aqueous interleukin-8 after multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis. ( 24874926 )
2014

Variations for Cytomegalovirus Retinitis

Expression for Cytomegalovirus Retinitis

Search GEO for disease gene expression data for Cytomegalovirus Retinitis.

Pathways for Cytomegalovirus Retinitis

Pathways related to Cytomegalovirus Retinitis according to GeneCards Suite gene sharing:

(show all 36)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.78 CCR2 CCR5 CSF2 HLA-B HLA-DQB1 IFNG
2
Show member pathways
13.45 CCR2 CCR5 CSF2 IFNG IL10RA TNF
3
Show member pathways
13.21 CCR2 CCR5 CSF2 IL10RA TNF
4
Show member pathways
13.1 CCR2 CCR5 CSF2 IL10RA TNF
5
Show member pathways
12.67 HLA-B HLA-DQB1 IFNG TNF
6
Show member pathways
12.67 CCR2 CCR5 CSF2 HLA-B HLA-DQB1 IFNG
7
Show member pathways
12.62 HLA-B HLA-DQB1 IFNG TNF
8
Show member pathways
12.46 HLA-DQB1 IFNG IL10RA TNF
9
Show member pathways
12.35 CSF2 HLA-B IFNG TNF
10
Show member pathways
12.25 CCR5 CSF2 IFNG TNF
11 12.23 CSF2 HLA-B HLA-DQB1 TNF
12
Show member pathways
12.16 CSF2 IFNG TNF
13 12.07 HLA-B HLA-DQB1 IFNG IL10RA
14
Show member pathways
12.06 CSF2 IFNG IL10RA
15
Show member pathways
12 HLA-B IFNG TNF
16 11.99 HLA-DQB1 IFNG IL10RA TNF
17 11.95 CCR2 CCR5 IL10RA
18 11.87 CCR2 IFNG TNF
19 11.85 CSF2 IFNG TNF
20
Show member pathways
11.83 CCR5 HLA-DQB1 IFNG IL10RA TNF
21 11.75 CSF2 IFNG TNF
22 11.7 CCR2 CCR5 IL10RA
23
Show member pathways
11.61 CSF2 IFNG TNF
24 11.61 CD9 CSF2 HLA-DQB1 TNF
25 11.6 CSF2 IFNG TNF
26 11.51 CSF2 HLA-DQB1 IFNG TNF
27 11.49 CCR2 CSF2 TNF
28
Show member pathways
11.47 CSF2 IFNG TNF
29 11.33 CCR2 IFNG TNF
30 11.24 HLA-B IFNG
31 11.21 IFNG TNF
32 11.2 IL10RA TNF
33
Show member pathways
11.18 CSF2 IFNG TNF
34 11.16 IFNG TNF
35 11.02 CSF2 IFNG TNF
36 10.71 CCR2 CCR5 CSF2 IL10RA TNF

GO Terms for Cytomegalovirus Retinitis

Cellular components related to Cytomegalovirus Retinitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 integral component of plasma membrane GO:0005887 9.65 CCR2 CCR5 CD9 HLA-B TNF
2 clathrin-coated endocytic vesicle membrane GO:0030669 9.32 CD9 HLA-DQB1
3 cell surface GO:0009986 9.26 CCR5 CD9 HLA-B TNF
4 integral component of lumenal side of endoplasmic reticulum membrane GO:0071556 9.16 HLA-B HLA-DQB1
5 external side of plasma membrane GO:0009897 8.92 CCR5 CD9 IFNG TNF

Biological processes related to Cytomegalovirus Retinitis according to GeneCards Suite gene sharing:

(show all 20)
id Name GO ID Score Top Affiliating Genes
1 cell surface receptor signaling pathway GO:0007166 9.77 CCR5 CD9 IFNG
2 MAPK cascade GO:0000165 9.76 CCR5 CSF2 TNF
3 positive regulation of nitric oxide biosynthetic process GO:0045429 9.58 IFNG TNF
4 interferon-gamma-mediated signaling pathway GO:0060333 9.58 HLA-B HLA-DQB1 IFNG
5 extrinsic apoptotic signaling pathway GO:0097191 9.57 IFNG TNF
6 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240 9.56 CSF2 TNF
7 protein import into nucleus, translocation GO:0000060 9.55 IFNG TNF
8 positive regulation of protein complex assembly GO:0031334 9.54 IFNG TNF
9 positive regulation of osteoclast differentiation GO:0045672 9.52 IFNG TNF
10 dendritic cell chemotaxis GO:0002407 9.51 CCR2 CCR5
11 antigen processing and presentation GO:0019882 9.5 HLA-B HLA-DQB1 IFNG
12 negative regulation of growth of symbiont in host GO:0044130 9.49 IFNG TNF
13 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.48 IFNG TNF
14 positive regulation of podosome assembly GO:0071803 9.46 CSF2 TNF
15 positive regulation of chemokine biosynthetic process GO:0045080 9.43 IFNG TNF
16 positive regulation of interleukin-23 production GO:0032747 9.37 CSF2 IFNG
17 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.26 IFNG TNF
18 cellular response to lipopolysaccharide GO:0071222 9.26 CCR5 CSF2 IFNG TNF
19 immune response GO:0006955 9.17 CCR2 CCR5 CSF2 HLA-B HLA-DQB1 IFNG
20 positive regulation of vitamin D biosynthetic process GO:0060557 9.16 IFNG TNF

Molecular functions related to Cytomegalovirus Retinitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.43 CSF2 IFNG TNF
2 peptide antigen binding GO:0042605 9.16 HLA-B HLA-DQB1
3 chemokine receptor activity GO:0004950 8.96 CCR2 CCR5
4 C-C chemokine receptor activity GO:0016493 8.62 CCR2 CCR5

Sources for Cytomegalovirus Retinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....